Sunshine Biopharma (SBFM) Non Operating Investment Income (2014 - 2015)
Sunshine Biopharma (SBFM) reported Non Operating Investment Income of -$513155.0 for Q2 2015, up 32.97% on a YoY basis from -$385929.9 in Q2 2014, and up 32.97% quarter-over-quarter from -$765513.0 in Q2 2014.
Sunshine Biopharma (SBFM) Non Operating Investment Income (2014 - 2015) Analysis & Trends
Sunshine Biopharma has reported Non Operating Investment Income for 2 years, with the latest figure at -$513155.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Sunshine Biopharma | 10.40 Mn | 3.49 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -513,155.00 |
| Jun 30, 2015 | -513,155.00 |
| Jun 30, 2014 | -765,513.00 |
| Jun 30, 2014 | -765,513.00 |